O
10.00
0.42 (4.38%)
| Previous Close | 9.58 |
| Open | 9.60 |
| Volume | 381,925 |
| Avg. Volume (3M) | 475,598 |
| Market Cap | 705,670,016 |
| Price / Book | 2.66 |
| 52 Weeks Range | |
| Earnings Date | 10 Mar 2025 - 14 Mar 2025 |
| Diluted EPS (TTM) | -1.82 |
| Total Debt/Equity (MRQ) | 3.63% |
| Current Ratio (MRQ) | 13.15 |
| Operating Cash Flow (TTM) | -108.88 M |
| Levered Free Cash Flow (TTM) | -65.46 M |
| Return on Assets (TTM) | -29.22% |
| Return on Equity (TTM) | -45.98% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Biotechnology (US) | Mixed | Mixed |
| Biotechnology (Global) | Mixed | Mixed | |
| Stock | Oric Pharmaceuticals, Inc. | Bullish | Bullish |
AIStockmoo Score
1.3
| Analyst Consensus | 5.0 |
| Insider Activity | NA |
| Price Volatility | -2.0 |
| Technical Moving Averages | 0.0 |
| Technical Oscillators | 2.0 |
| Average | 1.25 |
|
ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. |
|
| Sector | Healthcare |
| Industry | Biotechnology |
| Investment Style | Small Value |
| % Held by Insiders | 9.50% |
| % Held by Institutions | 102.20% |
Ownership
| Name | Date | Shares Held |
|---|---|---|
| Nextech Invest Ltd. | 30 Sep 2024 | 5,285,714 |
| Column Group Llc | 30 Sep 2024 | 3,540,777 |
| Commodore Capital Lp | 30 Sep 2024 | 2,000,000 |
| First Turn Management, Llc | 30 Sep 2024 | 1,451,037 |
| 52 Weeks Range | ||
| Price Target Range | ||
| High | 21.00 (HC Wainwright & Co., 110.00%) | Buy |
| Median | 20.00 (100.00%) | |
| Low | 17.00 (Jones Trading, 70.00%) | Buy |
| Average | 19.33 (93.30%) | |
| Total | 3 Buy | |
| Avg. Price @ Call | 9.12 | |
| Firm | Date | Target Price | Call | Price @ Call |
|---|---|---|---|---|
| HC Wainwright & Co. | 13 Jan 2025 | 21.00 (110.00%) | Buy | 8.60 |
| 04 Nov 2024 | 21.00 (110.00%) | Buy | 9.48 | |
| Jones Trading | 31 Oct 2024 | 17.00 (70.00%) | Buy | 9.38 |
| Wells Fargo | 31 Oct 2024 | 20.00 (100.00%) | Buy | 9.38 |
No data within this time range.
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2025 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |